Document is current
Any future updates will be listed below
-
Authors
Tang, Qiao
Wang, Chunrui
Li, Hu
Chen, Zhiwei
Zhang, Li
Zhang, Jing
Liu, Xiaoqing
Xue, Yunling
Qiu, Yue
Peng, Mingli
Zeng, Yi
Hu, Peng
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2100054116 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study
https://doi.org/10.1186/s12985-025-02632-x
- License Information
-
More Information
Article History
Received: 9 November 2024
Accepted: 14 January 2025
First Online: 13 February 2025
Declarations
:
: This study was approved by the Institutional Review 2 Board of the Second Affiliated Hospital of Chongqing Medical University and was registered with the Chinese Clinical Trial Registry (ChiCTR2100054116). The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki. Obtained informed consent forms signed by all participants.
: We obtained informed consent forms for publication for all participants.
: The authors have no conflicts of interest to declare.
